WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking ...

NEW YORK (Reuters Health) - In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S. as Chantix - were no more prone to depression or ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

CHICAGO — Two popular stop-smoking drugs are as safe for the heart as nicotine patches and dummy pills, according to research requested by U.S. and European regulators. The results come from an ...